PEC vs TAHO Pharma: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and TAHO Pharma (6467) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ TAHO Pharma

0%+2874%-100%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYTAHO PharmaYoY
Oct 2026NT$2.84 billion+102.0%NT$10,000—
Sep 2026NT$2.64 billion+100.0%NT$1.2 million—
Aug 2026NT$2.62 billion+105.4%NT$1.7 million+2,874.1%
Jul 2026NT$2.51 billion+92.6%NT$1.7 million—
Jun 2026NT$2.33 billion+94.9%NT$1.3 million—
May 2026NT$2.46 billion+108.5%NT$0-100.0%
Apr 2026NT$2.06 billion+68.3%NT$0-100.0%
Mar 2026NT$1.94 billion+64.4%NT$10,000-99.2%
Feb 2026NT$1.6 billion+56.7%NT$0-100.0%
Jan 2026NT$1.58 billion+49.8%NT$23,000-90.6%
Dec 2025NT$1.92 billion+69.9%NT$131,000—
Nov 2025NT$1.55 billion+53.0%NT$418,000—
Oct 2025NT$1.4 billion+53.6%NT$0—

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16